Late Phase Drug Development World Europe 2011

What is your end goal in your late phase drug development strategy? Is it to meet post-marketing commitments; be more efficient in evaluating real world safety and effectiveness data; maximise the commercial benefits of
a drug; meet regulatory requirements or be efficient in patient communication? Late Phase Drug Development World Europe 2011 will equip you with the tools to achieve these individual targets and unite all elements to strengthen your overall late phase strategy.

To guarantee a successful late phase drug development strategy you need to ensure you are ahead of the game and are meeting the challenges faced in phase IIIb/IV research, post approval studies, observational research and health outcomes. Late Phase Drug Development World Europe 2011 can do this for you with its excellent speakers, focused content and plentiful networking opportunities.